<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="right"><FONT size="2">As filed with the Securities and Exchange Commission on August 9, 2002
</FONT>
<P align="right"><FONT size="2">Registration No.&nbsp;33- ______
</FONT>

<P align="center"><FONT size="2">SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549
</FONT>
<P align="center"><FONT size="2">FORM S-8
</FONT>
<P align="center"><FONT size="2">REGISTRATION STATEMENT UNDER<BR>
THE SECURITIES ACT OF 1933
</FONT>
<P align="center"><FONT size="2"><B>NOVAVAX, INC.</B>
</FONT>

<center><FONT size="2">(Exact name of issuer as specified in its charter)
</FONT></center>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="75%">
<TR valign="bottom">
        <TD width="61%">&nbsp;</TD>
        <TD width="15%">&nbsp;</TD>
        <TD width="24%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2"><b>Delaware</b></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2"><b>
22-2816046</b></FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">(State or other jurisdiction of</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
(I.R.S. Employer</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">incorporation or organization)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Identification No.)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2"><B>8320 Guilford Road, Columbia, Maryland 21046</B>
</FONT>

<center><FONT size="2">(Address of Principal Executive Offices) (Zip Code)
</FONT></center>
<P align="center"><FONT size="2"><B>1995 STOCK OPTION PLAN</B>
</FONT>

<center><FONT size="2">(Full title of the plan)
</FONT></center>

<P align="center"><FONT size="2">John A. Spears<BR>
President &#038; Chief Executive Officer<BR>
Novavax, Inc.<BR>
8320 Guilford Road<BR>
Columbia, Maryland 21046<BR>
(Name and address of agent for service)
</FONT>
<P align="center"><FONT size="2"><B>(301)&nbsp;854-3900</B>
</FONT>

<center><FONT size="2">(Telephone number, including area code, of agent for service)
</FONT></center>

<P align="center"><FONT size="2">CALCULATION OF REGISTRATION FEE
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
        <TD width="22%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="13%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="16%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">Proposed</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">Proposed</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2">Title of</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">maximum</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">maximum</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2">securities</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">Amount</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">offering</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">aggregate</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">Amount of</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2">to be</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">to be</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">price</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">offering</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2">registration</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2"><u>registered</u></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>registered</u></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>per share</u></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>price</u></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>fee</u></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center">&nbsp;</TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD>&nbsp;</TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="center">&nbsp;</TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="center">&nbsp;</TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">Common Stock,
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left" valign="top"><FONT size="2">2,000,000</FONT></TD>
        <TD align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">$3.12 (1)
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">$6,240,000&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">$574.08&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">$.01 par value</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">shares
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>

</TABLE>
</CENTER>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
        <TD width="5%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="93%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">(1)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Estimated solely for the purpose of calculating the registration fee, and based upon the average of the high</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
and low prices of the Common Stock on the Nasdaq National Market on August 5, 2002, in accordance</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
with Rules 457(c) and 457(h) of the Securities Act of 1933.</FONT></TD>
</TR>

</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2">STATEMENT UNDER GENERAL INSTRUCTION E<BR>
REGISTRATION OF ADDITIONAL SECURITIES
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Registration Statement is being filed with respect to securities of
the same class and issuable under the same employee benefit plan as the
securities for which the Registrant filed a Registration Statement on Form&nbsp;S-8
with the Securities and Exchange Commission on December&nbsp;11, 1995, File No.
33-80279, a Registration Statement on Form&nbsp;S-8, File No.&nbsp;333-77611, filed on
May&nbsp;3, 1999, and a Registration Statement on Form&nbsp;S-8, File No.&nbsp;333-46000,
filed on September&nbsp;18, 2000, the contents of which are incorporated by
reference herein.
</FONT>
<P><FONT size="2">PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
</FONT>
<P><FONT size="2">Item&nbsp;3. &nbsp;&nbsp;<u>Incorporation of Documents by Reference</u>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents filed by the Registrant with the Securities and
Exchange Commission are hereby incorporated by reference in this Registration Statement:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">1.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Registrant&#146;s Annual Report on Form&nbsp;10-K for
the year ended December&nbsp;31, 2001;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">2.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Registrant&#146;s Current Report on Form&nbsp;8-K filed on July&nbsp;2, 2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">3.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Registrant&#146;s Quarterly Report on Form&nbsp;10-Q
for the quarter ended March&nbsp;31, 2002; and</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">4.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">Description of Registrant&#146;s Common Stock ($.01
par value) contained in the Registrant&#146;s Registration
Statement No.&nbsp;0-26770 on Form&nbsp;10 filed on September&nbsp;14, 1995
pursuant to Section&nbsp;12(b) of the Securities Exchange Act.</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <td width="2%"></td>
        <TD width="98%"></TD>
</TR>
<TR valign="top">
        <td><font size="2">&nbsp;</font></td>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, all documents subsequently filed by the Registrant
pursuant to Sections&nbsp;13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act prior to the filing of a post-effective amendment which
indicates that all securities offered hereby have been sold or which
deregisters all of such securities then remaining unsold, shall be deemed
to be incorporated by reference into this Registration Statement and to
be a part hereof from the date of filing of such documents.</FONT></TD>
</TR>

</TABLE>
<P><FONT size="2">Item&nbsp;5. &nbsp;&nbsp;<u>Interests of Named Experts and Counsel</u>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal matters in connection with the issuance of Common Stock offered
hereby have been passed upon for the Registrant by White &#038; McNamara, P.C. as
counsel to Registrant. David A. White, a stockholder and director of White &#038;
McNamara, P.C., owns 50,000 shares of the Common Stock of the Registrant.
</FONT>
<P><FONT size="2">Item&nbsp;8. &nbsp;&nbsp;<u>Exhibits</u>
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Exhibit&nbsp;Index immediately preceding the exhibits is incorporated
herein by reference.
</FONT>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form&nbsp;S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, on the 7th day of
August, 2002.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="55%">
<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD width="50%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD align="left" valign="top"><FONT size="2">NOVAVAX, INC</FONT></TD>
</TR>

<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD width="50%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD width="50%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD align="left" valign="top"><FONT size="2">By:&nbsp;&nbsp;&nbsp;<u>/s/ John A. Spears</u></FONT></TD>
</TR>

<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John A. Spears, President</FONT></TD>
</TR>

<TR valign="bottom">
        <td width="50%">&nbsp;</td>
        <TD align="left" valign="top"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2"><B>POWER OF ATTORNEY</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We, the undersigned officers and directors of Novavax, Inc., hereby
severally constitute John A. Spears, Dennis W. Genge and Ann McGeehan and each of them
singly, our true and lawful attorneys with full power to them, and each of them
singly, to sign for us and in our names in the capacities indicated below, the
Registration Statement on Form&nbsp;S-8 filed herewith and any and all subsequent
amendments to said Registration Statement, and generally to do all such things
in our names and behalf in our capacities as officers and directors to enable
Novavax, Inc. to comply with all requirements of the Securities and Exchange
Commission, hereby ratifying and confirming our signatures as they may be
signed by said attorneys, or any of them, to said Registration Statement and
any and all amendments thereto.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed below by the following persons in the capacities and
on the dates indicated.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2"><u>Signature</u></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>Title</u></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>Date</u></FONT></TD>
</TR>
<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ John A. Spears<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
President, Chief Executive Officer<Br>
and Director</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">John A. Spears</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">

</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ Dennis W. Genge<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Vice President, Treasurer and<Br>
Chief Financial Officer</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>


<TR valign="bottom">
        <TD valign="top"><FONT size="2">
Dennis W. Genge</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">

</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2"><hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August _, 2002</FONT></TD>
</TR>


<TR valign="bottom">
        <TD valign="top"><FONT size="2">
Gary C. Evans</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ Mitchell J. Kelly<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">
Mitchell J. Kelly</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ J. Michael Lazarus, M.D.<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">
J. Michael Lazarus, M.D.</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ John O. Marsh, Jr.<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">
John O. Marsh, Jr.</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ Michael A. McManus<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">
Michael A. McManus</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2">/s/ Denis M. O&#146;Donnell, M.D.<hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August 7, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">
Denis M. O&#146;Donnell, M.D.</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="23%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="12%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD align="left"><FONT size="2"><hr size="2" width="75%"></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">August _, 2002</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">
Ronald H. Walker</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
&nbsp;
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2"><u><B>Exhibit&nbsp;Index</u></B>
</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2">Exhibit</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="left"><FONT size="2"><u>Number</u></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="left"><FONT size="2"><u>Description</u></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center">&nbsp;</TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Opinion of White &#038; McNamara, P.C.</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Novavax, Inc. 1995 Stock Option Plan</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
(Incorporated by reference to Exhibit&nbsp;10.4 to</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
the Company&#146;s Registration Statement on Form&nbsp;10,</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
File No.&nbsp;0-26770, filed September&nbsp;14, 1995.)</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
First Amendment to Novavax, Inc.</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
1995 Stock Option Plan (Incorporated by</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
reference to Exhibit&nbsp;10.3 to the Company&#146;s</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Annual Report on Form&nbsp;10-K, File No.&nbsp;0-26770,</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
filed April&nbsp;15, 1999.)</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Second Amendment to Novavax, Inc.</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
1995 Stock Option Plan (Incorporated by</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
reference to Exhibit&nbsp;10.3 to the Company&#146;s</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Registration Statement on Form&nbsp;S-8, File No.&nbsp;333-46000,</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
filed September&nbsp;18, 2000.)</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Third Amendment to Novavax, Inc.</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
1995 Stock Option Plan</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Ernst &#038; Young, LLP</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of PricewaterhouseCoopers, LLP</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of White &#038; McNamara, P.C.</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
(included in Exhibit&nbsp;5)</FONT></TD>
</TR>

<TR valign="bottom">
        <TD width="8%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">24</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Power of Attorney (included in the signature pages</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
of this Registration Statement)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "w62805sv8.htm", "description": "REGISTRATION STATEMENT, FORM S-8", "secsgml_size_bytes": 32397}]
{"company-data": {"conformed-name": "NOVAVAX INC", "cik": "0001000694", "assigned-sic": "2836", "irs-number": "222816046", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-97931", "film-number": "02725463"}, "business-address": {"street1": "8320 GUILFORD RD", "street2": "STE C", "city": "COLUMBIA", "state": "MD", "zip": "21046", "phone": "3078543900"}, "mail-address": {"street1": "8320 GUILFORD ROAD SUITE C", "street2": "12111 PARKLAWN DR", "city": "COLUMBIA", "state": "MD", "zip": "21046"}}
sv8
As filed with the Securities and Exchange Commission on August 9, 2002
Registration No. 33- ______
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
NOVAVAX, INC.
(Exact name of issuer as specified in its charter)
Delaware
22-2816046
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
8320 Guilford Road, Columbia, Maryland 21046
(Address of Principal Executive Offices) (Zip Code)
1995 STOCK OPTION PLAN
(Full title of the plan)
John A. Spears
President & Chief Executive Officer
Novavax, Inc.
8320 Guilford Road
Columbia, Maryland 21046
(Name and address of agent for service)
(301) 854-3900
(Telephone number, including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Title of
maximum
maximum
securities
Amount
offering
aggregate
Amount of
to be
to be
price
offering
registration
registered
registered
per share
price
fee
Common Stock,
2,000,000
$3.12 (1)
$6,240,000
$574.08
$.01 par value
shares
(1)
Estimated solely for the purpose of calculating the registration fee, and based upon the average of the high
and low prices of the Common Stock on the Nasdaq National Market on August 5, 2002, in accordance
with Rules 457(c) and 457(h) of the Securities Act of 1933.
STATEMENT UNDER GENERAL INSTRUCTION E
REGISTRATION OF ADDITIONAL SECURITIES
This Registration Statement is being filed with respect to securities of
the same class and issuable under the same employee benefit plan as the
securities for which the Registrant filed a Registration Statement on Form S-8
with the Securities and Exchange Commission on December 11, 1995, File No.
33-80279, a Registration Statement on Form S-8, File No. 333-77611, filed on
May 3, 1999, and a Registration Statement on Form S-8, File No. 333-46000,
filed on September 18, 2000, the contents of which are incorporated by
reference herein.
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference
The following documents filed by the Registrant with the Securities and
Exchange Commission are hereby incorporated by reference in this Registration Statement:
1.
The Registrant's Annual Report on Form 10-K for
the year ended December 31, 2001;
2.
The Registrant's Current Report on Form 8-K filed on July 2, 2002;
3.
The Registrant's Quarterly Report on Form 10-Q
for the quarter ended March 31, 2002; and
4.
Description of Registrant's Common Stock ($.01
par value) contained in the Registrant's Registration
Statement No. 0-26770 on Form 10 filed on September 14, 1995
pursuant to Section 12(b) of the Securities Exchange Act.
In addition, all documents subsequently filed by the Registrant
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act prior to the filing of a post-effective amendment which
indicates that all securities offered hereby have been sold or which
deregisters all of such securities then remaining unsold, shall be deemed
to be incorporated by reference into this Registration Statement and to
be a part hereof from the date of filing of such documents.
Item 5.
Interests of Named Experts and Counsel
Legal matters in connection with the issuance of Common Stock offered
hereby have been passed upon for the Registrant by White & McNamara, P.C. as
counsel to Registrant. David A. White, a stockholder and director of White &
McNamara, P.C., owns 50,000 shares of the Common Stock of the Registrant.
Item 8.
Exhibits
The Exhibit Index immediately preceding the exhibits is incorporated
herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, on the 7th day of
August, 2002.
NOVAVAX, INC
By:
/s/ John A. Spears
John A. Spears, President
and Chief Executive Officer
POWER OF ATTORNEY
We, the undersigned officers and directors of Novavax, Inc., hereby
severally constitute John A. Spears, Dennis W. Genge and Ann McGeehan and each of them
singly, our true and lawful attorneys with full power to them, and each of them
singly, to sign for us and in our names in the capacities indicated below, the
Registration Statement on Form S-8 filed herewith and any and all subsequent
amendments to said Registration Statement, and generally to do all such things
in our names and behalf in our capacities as officers and directors to enable
Novavax, Inc. to comply with all requirements of the Securities and Exchange
Commission, hereby ratifying and confirming our signatures as they may be
signed by said attorneys, or any of them, to said Registration Statement and
any and all amendments thereto.
Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed below by the following persons in the capacities and
on the dates indicated.
Signature
Title
Date
/s/ John A. Spears
President, Chief Executive Officer
and Director
August 7, 2002
John A. Spears
/s/ Dennis W. Genge
Vice President, Treasurer and
Chief Financial Officer
August 7, 2002
Dennis W. Genge
Director
August _, 2002
Gary C. Evans
/s/ Mitchell J. Kelly
Director
August 7, 2002
Mitchell J. Kelly
/s/ J. Michael Lazarus, M.D.
Director
August 7, 2002
J. Michael Lazarus, M.D.
/s/ John O. Marsh, Jr.
Director
August 7, 2002
John O. Marsh, Jr.
/s/ Michael A. McManus
Director
August 7, 2002
Michael A. McManus
/s/ Denis M. O'Donnell, M.D.
Director
August 7, 2002
Denis M. O'Donnell, M.D.
Director
August _, 2002
Ronald H. Walker
Exhibit Index
Exhibit
Number
Description
5
Opinion of White & McNamara, P.C.
10.1
Novavax, Inc. 1995 Stock Option Plan
(Incorporated by reference to Exhibit 10.4 to
the Company's Registration Statement on Form 10,
File No. 0-26770, filed September 14, 1995.)
10.2
First Amendment to Novavax, Inc.
1995 Stock Option Plan (Incorporated by
reference to Exhibit 10.3 to the Company's
Annual Report on Form 10-K, File No. 0-26770,
filed April 15, 1999.)
10.3
Second Amendment to Novavax, Inc.
1995 Stock Option Plan (Incorporated by
reference to Exhibit 10.3 to the Company's
Registration Statement on Form S-8, File No. 333-46000,
filed September 18, 2000.)
10.4
Third Amendment to Novavax, Inc.
1995 Stock Option Plan
23.1
Consent of Ernst & Young, LLP
23.2
Consent of PricewaterhouseCoopers, LLP
23.3
Consent of White & McNamara, P.C.
(included in Exhibit 5)
24
Power of Attorney (included in the signature pages
of this Registration Statement)